Stay updated on Antiplatelet vs rtPA in Mild Stroke Clinical Trial
Sign up to get notified when there's something new on the Antiplatelet vs rtPA in Mild Stroke Clinical Trial page.

Latest updates to the Antiplatelet vs rtPA in Mild Stroke Clinical Trial page
- Check6 days agoChange DetectedPlatform/template update from v3.5.0 to v3.5.2; trial details, eligibility criteria, and study results remain unchanged.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision history updated: added Revision: v3.5.0 and removed Revision: v3.4.2.SummaryDifference0.1%

- Check70 days agoChange DetectedAdded a new site revision tag (v3.4.2); removed a government-funding notice and an older revision tag (v3.4.1).SummaryDifference0.4%

- Check77 days agoChange DetectedAdded a government funding notice banner and updated the site revision from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check84 days agoChange DetectedAdded a glossary display option and exposed the QC status label (Last Update Submitted that Met QC Criteria); the site revision was updated from v3.3.4 to v3.4.0 with related wording adjustments.SummaryDifference0.2%

- Check98 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. No study details or content are affected.SummaryDifference0.1%

Stay in the know with updates to Antiplatelet vs rtPA in Mild Stroke Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Antiplatelet vs rtPA in Mild Stroke Clinical Trial page.